Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
86 Cards in this Set
- Front
- Back
Clonidine is what type of drug and what are its adverse effects
|
a2 agonist; dry mouth, sedation, severe rebound hypertension
|
|
a2 agonist; side effects: dry mouth, sedation, severe rebound HTN
|
Clonidine
|
|
Methyldopa is what type of drug and what are its adverse effects
|
a2 agonist: sedation, positive Coombs' test
|
|
Reserpine: mechanism and SE
|
promote NE degradation; sedation, depression, nasal stuffiness, diarrhea
|
|
Guanethidine: mechanism and SE
|
inhibit release of NE by replacing it in vesicles; orthostatic and exercise hypotension, sexual dysfunction, diarrhea
|
|
Prazosin: mechanism and SE
|
a1 blocker; 1st dose orthostatic hypotension, dizziness, headache
|
|
Side effects of beta blockers
|
Impotence, asthma, CV effects (bradycardia, CHF, AV block), CNS effects (sedation, sleep alterations)
|
|
Nitroprusside toxicity
|
Cyanide toxicity
|
|
Diazoxide toxicity
|
Hyperglycemia (reduces insulin release, hypotension)
|
|
ACE inhibitor toxicities
|
Hyperkalemia, cough, angioedema, taste changes, hypotension, pregnancy problems (fetal renal damage), rash, increased renin
|
|
Losartan toxicities
|
Fetal renal toxicity, hyperkalemia
|
|
Hydralazine mechanism
|
Increased cGMP leads to smooth muscle relaxation Vasodilates arterioles > veins; AFTERLOAD reduction
|
|
Clinical use of hydralazine
|
Severe hypertension, CHF. First lien therapy for hypertension in pregnancy, with methyldopa
|
|
Increased cGMP leads to smooth muscle relaxation Vasodilates arterioles > veins; AFTERLOAD reduction
|
Hydralazine
|
|
toxicity of hydralazine
|
Compensatory tachycardia (contraindicated in angina/CAD), fluid retention, nausea, headache, angina. Lupus like syndrome
|
|
Mechanism of Minoxidil
|
K+ channel opener - hyperpolarizes and relaxes vascular smooth muscle.
|
|
Clinical use of minoxidil
|
Severe HTN
|
|
Toxicity of Minoxidil
|
Hypertrichosis, pericardial effusion, reflex tachycardia, angina, salt retention
|
|
Vasodilator. K+ channel opener - hyperpolarizes and relaxes vascular smooth muscle.
|
Minoxidil
|
|
Name 3 commonly used calcium channel blockers
|
Nifedipine, verapamil, diltiazem
|
|
Mechanism of action for Nifedipine
|
Block voltage dependent L-type calcium channels of cardiac and smooth muscle and thereby reduce muscle contractility for VESSELS mainly (not really heart)
|
|
What are the clinical uses of Nifedipine, Verapamil, and diltiazem
|
HTN, angina, arrhythmias (notnifedipine), Prinzmetal's angina, Raynaud's
|
|
Toxicities of nifedipine
|
Peripheral edema, flushing, dizziness, and constipation
|
|
Toxicities of verapamil and diltiazem
|
Cardiac depression, flushing, dizziness, and constipation
|
|
Mechanism of Nitroglycerin
|
Vasodilate by releasing NO in smooth muscles, increasing cGMP and smooth muscle relaxation. Dilate veins >> arteries decreasing preload.
|
|
Clinical uses of Nitroglycerin or isosorbide dinitrate
|
Angina, pulmonary edema. also used as an aphrodisiac and erection enhancer
|
|
"Monday disease" in indusrial exposure - development of tolerance during work week and loss of tolerance over weeend resulting in tachycardia, dizziness, and headache on reexposure. what drug?
|
Nitroglycerin or Isosorbide dinitrate
|
|
Three treatments for malignant hypertension
|
Nitroprusside, Fenoldopam, Diazoxide
|
|
Mechanism of action of Nitroprusside
|
Short acting, increases cGMP via direct release of NO
|
|
Mechanims of action of Fenoldopam
|
Dopamine D1 receptor agonist - relaxes renal vascular smooth muscle
|
|
Dopamine D1 receptor agonist - relaxes renal vascular smooth muscle
|
Fenoldopam
|
|
Diazoxide mechanism
|
K+ channel opener - hyperpolarizes and relaxes vascular SM
|
|
K+ channel opener - hyperpolarizes and relaxes vascular SM
|
Diazoxide
|
|
Which beta blockers are also parital B agonists and contraindicated in angina
|
Pindolol and acebutolol
|
|
Side effects of HMG-CoA reductase
|
Reversible increase in LFTs, rhabdomyolisis
|
|
Simvastatin inhibits the formation of what cholesterol precursor?
|
Mevalonate
|
|
Which lipid lowering agent has the highest effect in raising HDL?
|
Niacin
|
|
What is the mechanisms of action of niacin?
|
Inhibit lipolysis in adipose tissue; reduces hepatic VLDL secretion into circulation
|
|
Cholestyramine and colsevelam are examples of
|
Bile acid resins
|
|
Which lipid lowering agent is contraindicated in pts with gallstones?
|
Cholestyramine, colestipol (bile acid resins)
|
|
What are the side effects of colestipol, cholestyramine?
|
Patients hate it - tastes bad and causes GI discomfort, decreased absorption of fat-soluble vitamins
|
|
Name of cholesterol absorption blocker
|
Ezetimibe
|
|
Toxicity of ezetimibe
|
Rare incrase in LFTs
|
|
Mechanism of ezetimibe
|
Prevent cholesterol reabsorption at small intestine brush border
|
|
Fenofibrate, clofibrate mechanims
|
Upregulate LPL causing increased TG clearance
|
|
Side effects of gemfibrozil, bezafibrate
|
Myositis, increased LFTs
|
|
B1 receptors on cardiac cells are what G protein motif which end up doing what
|
Gs, activate PKA and phosphorylates L-type Ca2+ channels and phospholamban, both of which increase intracellular Ca2+ druing contraction
|
|
Mechanism of action of digoxin
|
Direct inhibition of Na+/K+ ATPase leads to indirect inhibition of Na+/Ca2+ exchanger/antiport. Increased Ca results in positive inotropy. Also stimuates vagus nerve
|
|
Clinical uses of digoxin
|
CHF (Increase contractility) and AFib (Decrease conduction at AV node and depression of SA node)
|
|
Toxicity of digoxin seen on eCG
|
Increased PR, Dec QT, scooping ST segment, T wave inversion on ECG
|
|
What increases the toxicities of digoxin?
|
Renal failure (Decreased excretion), hypokalemia (digoxin competes with K+ at binding site in Na+/K+ ATPase so decreased K+ means increased digoxin biding and effect), and quinidine (decreased digoxin clearance, displaces digoxin from tissue binding sites)
|
|
Antidote for digoxin poisoning
|
Slowly normalize K+, lidocaine, cardiac pacer, anti-dig Fab fragments, Mg2+
|
|
AP length effect on Class IA, IB, IC antiarrythmics
|
1A: Increase 1B: Decrease 1C: No effect
|
|
What class antiarrhythmic is Disopyramide?
|
IA
|
|
Class 1A antiarrythmics are used for what abnormalities?
|
Atrial and ventricular arrhythmias, esp reentrant and ectopic supraventricular and ventricular tachycardia
|
|
Toxicity of quinidine
|
Cinchonism - headache, tinnitus, thrombocytopenia; Torsades de pointes due to increased QT interval
|
|
Toxicity of procainamide
|
Reversible SLE-like syndrome
|
|
What are the Class 1B antiarrythmics?
|
Lidocaine, Mexiletine, Tocainide
|
|
What abnormalities does Mexiletine and it's class correct?
|
Affects ischemic or depolarized Purkinje and ventricular tissue. Useful in acute ventricular arrhythmias (esp post M!) and in digitalis induced arrhythmias NO EFFECT on atrial arrythmias
|
|
Toxicities of Class 1B antiarrhythmics
|
Local anesthetic, CNS stimulation/depression, cardiovascular depression
|
|
What are the class 1C antiarrythmics
|
Flecainide, encainide, propafenone
|
|
What are Class 1C antiarrhythmics used for?
|
V-tachs that progress to VF and in intractable SVT. usually used only as last resort in refractory tachyarrhythmias. For patients without structural abnormalities
|
|
Toxicities of Class 1C antiarrhythmics
|
Proarrhythmic, esp post-MI (contraindicated), significantly prolongs refractory period in AV node
|
|
What causes increased toxicity for all class I drugs?
|
Hyperkalemia
|
|
What is the mechanism of Class II antiarrhythmics?
|
B-blockers - decrease cAMP, decrease Ca2+ currents. Suppress abnomral pacemakers by decreasing slope of phase 4. AV node particularly sensitive increasing the PR interval.
|
|
Which of the Class II antiarrhythmics are the shortest acting?
|
Esmolol
|
|
What are the clinical uses for metoprolol, esmolol, etc.?
|
V-tach, SVT, slowling ventricular rate during Afib and A. flutter
|
|
What is a toxicity particular to metoprolol
|
Dyslipidemia
|
|
Name 4 commonly used Class III antiarrhthmics
|
Sotalol, ibutilide, amiodarone, dofetilide
|
|
What is the mechanism of action of Class III antiarrythmics?
|
Increase AP duration, increase effective refractory period. Increases QT interval
|
|
Which class of antiarrhythmics is state dependent?
|
Class I (selectively depress tissue that is frequently depolarized)
|
|
When is Class III antiarrhythmics used?
|
When other antiarrhythmics fail
|
|
Toxicity of sotalol
|
Torsades de pointes, excessive B block (sotalol is a racemic mixture with class III and beta-blocker)
|
|
What is the toxicity of ibutilide?
|
Torsades de pointes
|
|
Toxicities of amiodarone?
|
Pulmonary fibrosis, corneal depsoits, hepatotoxicity, skin deposits resulting in photodermatitis, neurologic effects, constipation, CV effects(bradycardia, heart block, CHF), hypothyroidism/hyperthyroidism
|
|
What needs to be checked when using amiodarone?'
|
TFTs, PFTs, LFTs
|
|
What class of antiarrythmics have Torsades as potential toxicity?
|
Class III, Class 1A (Increased QT intervals)
|
|
Name the two Class IV antiarrhythmics commonly used
|
Verapamil, diltiazem
|
|
Mechanism of Class IV antiarrythmics
|
Ca2+ channel blockers. Primarily affect AV cells. Decrease condiction velocity, Inc ERP, Inc PR interval, used in prevention of nodal arrhythmias (SVT)
|
|
Which two class of antiarrythmics primarily affect AV nodal cells?
|
Class II and Class IV
|
|
Toxicities of Class IV antiarrythmics
|
Constipation, flushing, edema, CV effects (CHF, AV block, sinus node depression)
|
|
Mechanism of Adenosine as an antiarrythmic
|
Increase K+ out of cells, hyperpolarizing cell and decreasing Ca+
|
|
What is the drug of choice in diagnosing/abolishing AV nodal arrythmias?
|
Adenosine
|
|
What are the toxicities of adenosine
|
Flushing, hypotension, chest pain
|
|
K+ is used as an antiarrhythmic how?
|
Depresses ectopic pacemakers in hypokalemia (digoxin toxicity)
|
|
What is Mg2+ used for as an antiarrythmic
|
Torsades de pointes and digoxin toxicity
|